Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04032080
Title Treatment With Oral LY3023414 To Inhibit Homologous Recombination Followed By Prexasertib (ExIST)
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Baylor Research Institute
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.